logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Joseph M. Connors

british columbia cancer agency
H指数:120
被引数:9.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma

Brentuximab Vedotin在III期或IV期霍奇金淋巴瘤中的总体生存率

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2022-07-28158
OA
Ansell, Stephen M.; Radford, John; Connors, Joseph M.; Dlugosz-Danecka, Monika; Kim, Won-Seog; Gallamini, Andrea; Ramchandren, Radhakrishnan; Friedberg, Jonathan W.; Advani, Ranjana; Hutchings, Martin; Evens, Andrew M.; Smolewski, Piotr; Savage, Kerry J.; Bartlett, Nancy L.; Eom, Hyeon-Seok; Abramson, Jeremy S.; Dong, Cassie; Campana, Frank; Fenton, Keenan; Puhlmann, Markus; Straus, David J.
Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma
JOURNAL OF CLINICAL INVESTIGATION
IF13.6
2022-05-1613
OAAI
Takata, Katsuyoshi; Chong, Lauren C.; Ennishi, Daisuke; Aoki, Tomohiro; Li, Michael Yu; Thakur, Avinash; Healy, Shannon; Vigano, Elena; Dao, Tao; Kwon, Daniel; Duns, Gerben; Nielsen, Julie S.; Ben-Neriah, Susana; Tse, Ethan; Hung, Stacy S.; Boyle, Merrill; Mun, Sung Soo; Bourne, Christopher M.; Woolcock, Bruce; Telenius, Adele; Kishida, Makoto; Rai, Shinya; Zhang, Allen W.; Bashashati, Ali; Saberi, Saeed; D'Antonio, Gianluca; Nelson, Brad H.; Shah, Sohrab P.; Hoodless, Pamela A.; Melnick, Ari M.; Gascoyne, Randy D.; Connors, Joseph M.; Scheinberg, David A.; Beguelin, Wendy; Scott, David W.; Steidl, Christian
Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach

局限性结节性淋巴细胞为主的霍奇金淋巴瘤的结局以及PET适应方法的影响

BLOOD ADVANCES
IF7.1
2021-09-246
OA
Cheng, Phoebe T. M.; Villa, Diego; Tonseth, R. Petter; Scott, David W.; Gerrie, Alina S.; Freeman, Ciara L.; Pickles, Tom; Lo, Andrea C.; Farinha, Pedro; Craig, Jeffrey W.; Slack, Graham W.; Gascoyne, Randy D.; Benard, Francois; Wilson, Don; Skinnider, Brian; Connors, Joseph M.; Sehn, Laurie H.; Savage, Kerry J.
Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study

先前未经治疗的晚期经典霍奇金淋巴瘤的老年患者 (年龄 ≥ 60岁): 来自III期ECHELON-1研究的详细分析

HAEMATOLOGICA
IF7.9
2021-06-2440
OAAI
Evens, Andrew M.; Connors, Joseph M.; Younes, Anas; Ansell, Stephen M.; Kim, Won Seog; Radford, John; Feldman, Tatyana; Tuscano, Joseph; Savage, Kerry J.; Oki, Yasuhiro; Grigg, Andrew; Pocock, Christopher; Dlugosz-Danecka, Monika; Fenton, Keenan; Forero-Torres, Andres; Liu, Rachael; Jolin, Hina; Gautam, Ashish; Gallamini, Andrea
Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial

Brentuximab vedotin联合化疗治疗III期或IV期经典霍奇金淋巴瘤 (ECHELON-1): 一项国际、开放标签、随机、3期试验的5年更新

LANCET HAEMATOLOGY
IF17.7
2021-06-0198
PRE
Straus, David J.; Dlugosz-Danecka, Monika; Connors, Joseph M.; Alekseev, Sergey; Illes, Arpad; Picardi, Marco; Lech-Maranda, Ewa; Feldman, Tatyana; Smolewski, Piotr; Savage, Kerry J.; Bartlett, Nancy L.; Walewski, Jan; Ramchandren, Radhakrishnan; Zinzani, Pier Luigi; Hutchings, Martin; Munoz, Javier; Lee, Hun Ju; Kim, Won Seog; Advani, Ranjana; Ansell, Stephen M.; Younes, Anas; Gallamini, Andrea; Liu, Rachael; Little, Meredith; Fenton, Keenan; Fanale, Michelle; Radford, John
Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study
HEMATOLOGICAL ONCOLOGY
IF3.9
2021-02-1615
OAAI
Hutchings, Martin; Radford, John; Ansell, Stephen M.; Illes, Arpad; Sureda, Anna; Connors, Joseph M.; Sykorova, Alice; Shibayama, Hirohiko; Abramson, Jeremy S.; Chua, Neil S.; Friedberg, Jonathan W.; Koren, Jan; LaCasce, Ann Steward; Molina, Lysiane; Engley, Gerald; Fenton, Keenan; Jolin, Hina; Liu, Rachael; Gautam, Ashish; Gallamini, Andrea
Hodgkin lymphoma

霍奇金淋巴瘤

NATURE REVIEWS DISEASE PRIMERS
IF60.6
2020-07-23129
PREAI
Connors, Joseph M.; Cozen, Wendy; Steidl, Christian; Carbone, Antonino; Hoppe, Richard T.; Flechtner, Hans-Henning; Bartlett, Nancy L.
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma
BLOOD ADVANCES
IF7.1
2020-06-2669
OAAI
Rushton, Christopher K.; Arthur, Sarah E.; Alcaide, Miguel; Cheung, Matthew; Jiang, Aixiang; Coyle, Krysta M.; Cleary, Kirstie L. S.; Thomas, Nicole; Hilton, Laura K.; Michaud, Neil; Daigle, Scott; Davidson, Jordan; Bushell, Kevin; Yu, Stephen; Rys, Ryan N.; Jain, Michael; Shepherd, Lois; Marra, Marco A.; Kuruvilla, John; Crump, Michael; Mann, Koren; Assouline, Sarit; Connors, Joseph M.; Steidl, Christian; Cragg, Mark S.; Scott, David W.; Johnson, Nathalie A.; Morin, Ryan D.
TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma
NATURE MEDICINE
IF50
2020-02-2455
OAAI
Ennishi, Daisuke; Healy, Shannon; Bashashati, Ali; Saberi, Saeed; Hother, Christoffer; Mottok, Anja; Chan, Fong Chun; Chong, Lauren; Abraham, Libin; Kridel, Robert; Boyle, Merrill; Meissner, Barbara; Aoki, Tomohiro; Takata, Katsuyoshi; Woolcock, Bruce W.; Vigano, Elena; Gold, Michael; Molday, Laurie L.; Molday, Robert S.; Telenius, Adele; Li, Michael Y.; Wretham, Nicole; Dos Santos, Nancy; Wong, Mark; Viller, Natasja N.; Uger, Robert A.; Duns, Gerben; Baticados, Abigail; Madero, Angel; Bristow, Brianna N.; Farinha, Pedro; Slack, Graham W.; Ben-Neriah, Susana; Lai, Daniel; Zhang, Allen W.; Salehi, Sohrab; Shulha, Hennady P.; Chiu, Derek S.; Mostafavi, Sara; Gerrie, Alina S.; Huang, Da Wei; Rushton, Christopher; Villa, Diego; Sehn, Laurie H.; Savage, Kerry J.; Mungall, Andrew J.; Weng, Andrew P.; Bally, Marcel B.; Morin, Ryan D.; Cohen Freue, Gabriela V.; Staudt, Louis M.; Connors, Joseph M.; Marra, Marco A.; Shah, Sohrab P.; Gascoyne, Randy D.; Scott, David W.; Steidl, Christian
COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study

COO和MYC/BCL2状态不能预测I/II期DLBCL患者的预后: 一项回顾性多中心研究

BLOOD ADVANCES
IF7.1
2019-07-0840
OA
Barraclough, Allison; Alzahrani, Musa; Ettrup, Marianne Schmidt; Bishton, Mark; van Vliet, Chris; Farinha, Pedro; Gould, Clare; Birch, Simone; Sehn, Laurie H.; Sovani, Vishakha; Ward, Mitchell Steven; Augustson, Bradley; Biccler, Jorne; Connors, Joseph M.; Scott, David W.; Gandhi, Maher K.; Savage, Kerry J.; El-Galaly, Tarec; Villa, Diego; Cheah, Chan Yoon

研究方向

暂未获取到该数据
R
Randy D. Gascoyne
H 指数:152论文数:1,004被引数:10.7万
K
Kerry J. Savage
H 指数:84论文数:639被引数:3.7万
L
Laurie H. Sehn
H 指数:82论文数:658被引数:3.0万
D
David W. Scott
H 指数:66论文数:524被引数:2.0万
C
Christian Steidl
H 指数:79论文数:583被引数:2.2万
M
Marco A. Marra
H 指数:190论文数:1,320被引数:24.0万
D
Diego Villa
H 指数:44论文数:352被引数:7,394
R
Ryan D. Morin
H 指数:65论文数:424被引数:2.1万
L
Louis M. Staudt
H 指数:145论文数:802被引数:9.7万
E
Elı́as Campo
H 指数:173论文数:1,569被引数:16.5万